Parenteral Nutrition Clinical Trial
Official title:
EPICOS- Evaluating the Influence of RTU Parenteral Nutrition in the Clinical Outcome Patients Study
This is an international prospective randomized multicenter open-label controlled study. The primary center will be Fernandes Távora Hospital (Fortaleza, Ceará). The aim of this study is to investigate the effects of closed parenteral nutrition systems when compared to open parenteral nutrition systems in terms of several clinical outcomes.
In most Latin-American countries individually customized nutrition formulations (CNF)
remains the gold-standard for parenteral nutrition in opposition to industrialized
ready-to-use parenteral nutrition (RTU). Although CNF is possibly associated with elevated
infection rates, delay in the start of enteral nutrition and worse clinical outcomes there
is no strong scientific evidence in the literature to support that the use of RTU is indeed
associated with better clinical outcomes.
The use of closed ready-to-use parenteral nutrition systems is probably associated with less
infection rates and better clinical outcomes including less time at the hospital and at the
intensive care unit, less consumption of hospital resources and most likely lower mortality
rates as well as early initiation of parenteral nutrition support. The aim of this study is
to evaluate all the above mentioned parameters in contrast with those observed when using
CNF parenteral nutrition.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03606863 -
Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS
|
Phase 3 | |
Completed |
NCT00451646 -
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
|
Phase 3 | |
Completed |
NCT04006730 -
Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
|
||
Enrolling by invitation |
NCT06161350 -
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
|
||
Completed |
NCT04234152 -
Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study
|
N/A | |
Completed |
NCT00672854 -
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT01839617 -
Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery
|
N/A | |
Completed |
NCT05299099 -
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301
|
Phase 3 | |
Withdrawn |
NCT02463812 -
Lipid Infusion Following Major Surgery
|
N/A | |
Completed |
NCT04816734 -
Initial Parenteral Nutrition Education of Parent Assessment Plan
|
N/A | |
Terminated |
NCT01814956 -
Different Lipid Emulsions in Acute Lung Injury Patients
|
Phase 4 | |
Completed |
NCT04234490 -
Longitudinal Evaluation of the Impact of Parenteral Nutrition
|
||
Recruiting |
NCT05519761 -
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
|
||
Completed |
NCT00321165 -
The AOT (Acridine Orange and Taurolidine) Trial
|
Phase 3 | |
Completed |
NCT00292279 -
The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients
|
Phase 3 | |
Recruiting |
NCT03157245 -
Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery
|
N/A | |
Recruiting |
NCT03693287 -
Personalized vs Standardized PN for Preterm Infants >1250g
|
Phase 4 | |
Completed |
NCT02828150 -
Integrative Parenteral Nutrition in Cancer Patients
|
N/A | |
Completed |
NCT00512629 -
Cholestasis Prevention: Efficacy of IV Fish Oil
|
Phase 1 | |
Completed |
NCT03792100 -
Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition
|
Phase 3 |